---
title: Carbogen Amcis vs Rotop Pharmaka GmbH
slug_a: carbogen-amcis
slug_b: rotop-pharmaka
site: cdmo
review_signal_gate: closed
canonical_path: /compare/carbogen-amcis/rotop-pharmaka
generated_by: BioBM Editorial AI
---

# Carbogen Amcis vs Rotop Pharmaka GmbH

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Carbogen Amcis (carbogen-amcis) is listed for cdmo. Full-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales.

Services: 18. Modalities: 2. Indications: 0. Locations: 14. Certifications: 5. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (18).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Rotop Pharmaka GmbH (rotop-pharmaka) is listed for cdmo. ROTOP is a leading radiopharmaceutical CDMO based in Dresden, Germany, offering end-to-end development and cGMP manufacturing of cold kits and ready-to-use radiopharmaceuticals for diagnostic imaging and therapy, with over 25 years of expertise and distribution to 40+ countries.

Services: 11. Modalities: 1. Indications: 3. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (11).

Review summary: Review summary withheld until site-level review gate opens.